Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	124-126
Number of pages	3
Journal	BMJ Evidence-Based Medicine: expertise, values, evidence
Volume	30
Issue number	2
Early online date	5 Jun 2024
DOIs	https://doi.org/10.1136/bmjebm-2024-112907
Publication status	Published - 1 Apr 2025

Access to Document

@article{6d728843597742c6ba31a1dc371ab0c0,

title = "Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting",

author = "Zijun Wang and Burgers, \{Jako S\} and Ruitai Shao and Zhaoxiang Bian and Chen Wang and Yaolong Chen and Janne Estill",

year = "2025",

month = apr,

day = "1",

doi = "10.1136/bmjebm-2024-112907",

language = "English",

volume = "30",

pages = "124--126",

journal = "BMJ Evidence-Based Medicine: expertise, values, evidence",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Strengthening transparency in randomised trials related to multimorbidity

T2 - key points and recommendations to guide reporting

AU - Wang, Zijun

AU - Burgers, Jako S

AU - Shao, Ruitai

AU - Bian, Zhaoxiang

AU - Wang, Chen

AU - Chen, Yaolong

AU - Estill, Janne

PY - 2025/4/1

Y1 - 2025/4/1

U2 - 10.1136/bmjebm-2024-112907

DO - 10.1136/bmjebm-2024-112907

M3 - Article

SN - 2515-446X

VL - 30

SP - 124

EP - 126

JO - BMJ Evidence-Based Medicine: expertise, values, evidence

JF - BMJ Evidence-Based Medicine: expertise, values, evidence

IS - 2

ER -